Jinhe Biotechnology Company Overview
- Year Founded
-
1990
- Status
-
Public
- Employees
-
2,476
- Stock Symbol
-
002688
- Investments
-
3
- Share Price
-
$0.97
- (As of Thursday Closing)
Jinhe Biotechnology Company General Information
Description
Jinhe Biotechnology Co Ltd is engaged in manufacturing veterinary feed additives, veterinary vaccines, veterinary chemicals, corn starch processing and industrial wastewater treatments business.
Contact Information
Website
www.jinhe.com.cnCorporate Office
- 2-25-1 Building 22
- Zone B3 Xinghai Plaza
- Dalian, Shahekou
- China
Corporate Office
- 2-25-1 Building 22
- Zone B3 Xinghai Plaza
- Dalian, Shahekou
- China
Jinhe Biotechnology Company Stock Performance
As of 10-Jul-2025, Jinhe Biotechnology Company’s stock price is $0.97. Its current market cap is $749M with 772M shares.
(As of Thursday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $0.97 | $0.93 | $0.48 - $1.18 | $749M | 772M | 75.6M | $0.02 |
Jinhe Biotechnology Company Financials Summary
As of 31-Mar-2025, Jinhe Biotechnology Company has a trailing 12-month revenue of $344M.
|
In Thousands, USD |
TTM 31-Mar-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 | FY 2022 31-Dec-2022 |
|---|---|---|---|---|
| EV | 767,481 | 738,560 | 786,777 | 727,512 |
| Revenue | 343,687 | 330,380 | 307,303 | 315,197 |
| EBITDA | 13,003 | 38,228 | 37,221 | 41,979 |
| Net Income | 14,736 | 13,964 | 12,220 | 11,228 |
| Total Assets | 782,242 | 774,042 | 769,377 | 653,474 |
| Total Debt | 323,165 | 317,659 | 324,439 | 232,156 |
Jinhe Biotechnology Company Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Jinhe Biotechnology Company Investments & Acquisitions (3)
Jinhe Biotechnology Company’s most recent deal was a Merger/Acquisition with Jilin Baisiwanke for . The deal was made on 24-May-2023.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Jilin Baisiwanke | 24-May-2023 | Merger/Acquisition | Biotechnology | ||
| American Protech | 01-Jan-2016 | Merger/Acquisition | Other Commercial Services | ||
| Pharmgate | 12-Sep-2012 | Secondary Transaction - Private | Other Pharmaceuticals and Biotechnology |
Jinhe Biotechnology Company Affiliates
Subsidiaries (2)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Jilin Baisiwanke | Tonghua, China | 2021 | |
| Pharmgate | Wilmington, NC | 2008 |
Jinhe Biotechnology Company FAQs
-
When was Jinhe Biotechnology Company founded?
Jinhe Biotechnology Company was founded in 1990.
-
Where is Jinhe Biotechnology Company headquartered?
Jinhe Biotechnology Company is headquartered in Dalian, China.
-
What is the size of Jinhe Biotechnology Company?
Jinhe Biotechnology Company has 2,476 total employees.
-
What industry is Jinhe Biotechnology Company in?
Jinhe Biotechnology Company’s primary industry is Other Consumer Non-Durables.
-
Is Jinhe Biotechnology Company a private or public company?
Jinhe Biotechnology Company is a Public company.
-
What is Jinhe Biotechnology Company’s stock symbol?
The ticker symbol for Jinhe Biotechnology Company is 002688.
-
What is the current stock price of Jinhe Biotechnology Company?
As of 10-Jul-2025 the stock price of Jinhe Biotechnology Company is $0.97.
-
What is the current market cap of Jinhe Biotechnology Company?
The current market capitalization of Jinhe Biotechnology Company is $749M.
-
What is Jinhe Biotechnology Company’s current revenue?
The trailing twelve month revenue for Jinhe Biotechnology Company is $344M.
-
What is Jinhe Biotechnology Company’s annual earnings per share (EPS)?
Jinhe Biotechnology Company’s EPS for 12 months was $0.02.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
